Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

AI Readiness in the Industrial Sector - Do's and Don'ts

To our first edition of "The AI Interview" series on AI Readiness in the Industrial Sector.

Transforming complex AI challenges into real impact: The intelligent healthcare system for the next decade

How AI, collaboration, and secure data infrastructures are redefining research, diagnostics, and care, paving the way for the intelligent healthcare system of the next decade.

Article

Building the AI-Native Enterprise: A Cultural and Operational Transformation from Within

How companies are not only introducing AI, but also holistically transforming their culture, governance, and working methods into AI-native organizations.

Article

Our publications

Discover the latest publications from our research team and more

Event

Events

A new approach to administration: The AI Innovation Space for genuine process acceleration

Germany is setting new standards in the digitization of public administration. At the AI Innovation Hub, you can experience how agent-based AI supports complex administrative procedures from start to finish, accelerates decision-making processes, and noticeably reduces the workload for public authorities. See for yourself how this innovation works in practice and what concrete benefits it can bring to your institution—interactively, clearly, and directly transferable.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.